Elefante C, Brancati GE, Torrigiani S, Amadori S, Ricciardulli S, Pistolesi G · Curr Neuropharmacol (2023)
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
32 peer-reviewed studies
What the evidence says
Most Lithium Orotate studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 1988–2026 with a typical study size of 60 participants.
Based on 32 studies · 2 meta-analyses · 13 RCTs · 6,933 total participants
Confidence
High confidenceBy outcome
20 studies in the last 5 years · Latest meta-analysis: 2024
Elefante C, Brancati GE, Torrigiani S, Amadori S, Ricciardulli S, Pistolesi G · Curr Neuropharmacol (2023)
Brown EE, Gerretsen P, Pollock B, Graff-Guerrero A · Med Hypotheses (2018)
In plain English: Low-dose lithium may be safer than aducanumab, lecanemab and donanemab.
Terao I, Kodama W. · Ageing research reviews (2024)
Strawbridge R, Kerr-Gaffney J, Bessa G, Loschi G, Freitas HLO, Pires H · Neurosci Biobehav Rev (2023)
Mauer S, Vergne D, Ghaemi SN · Aust N Z J Psychiatry (2014)
Zusky PM, Biederman J, Rosenbaum JF, Manschreck TC, Gross CC, Weilberg JB · J Clin Psychopharmacol (1988)
Abou-Saleh MT, Coppen A · J Psychiatr Res (1989)
Devanand DP, Crocco E, Forester BP, Husain MM, Lee S, Vahia IV · Am J Geriatr Psychiatry (2022)
Allain P, Le Bouil A, Turcant A, Molinier P, Armand P, Andrianiriana F · Therapie (1994)
Wilson KC, Scott M, Abou-Saleh M, Burns R, Copeland JR · Br J Psychiatry (1995)
Aprahamian I, Santos FS, dos Santos B, Talib L, Diniz BS, Radanovic M · J Clin Psychiatry (2014)
Wilkinson D, Holmes C, Woolford J, Stammers S, North J · Int J Geriatr Psychiatry (2002)
Deliyannides DA, Graff JA, Niño I, Lee S, Husain MM, Forester BP · Int J Geriatr Psychiatry (2023)
Perlis RH, Sachs GS, Lafer B, Otto MW, Faraone SV, Kane JM · Am J Psychiatry (2002)
Gonzalez Arnold J, Salcedo S, Ketter TA, Calabrese JR, Rabideau DJ, Nierenberg AA · J Affect Disord (2015)
Forlenza OV, Coutinho AM, Aprahamian I, Prando S, Mendes LL, Diniz BS · ACS Chem Neurosci (2014)
In plain English: Further research should seek to replicate similar findings in larger samples and explore lithium's optimal dosage range in promoting intracerebral amyloid clearance.
Xiao K, Sayed H, Xing J, Zhang XY, Ai J, Kirichek E, Le GH, Wong S, Valentino K, Teopiz KM, Vinberg M, Rosenblat JD, Lo HKY, Zhang MC, McIntyre RS. · Journal of affective disorders (2026)
In plain English: This pilot randomized clinical trial established feasibility, confirmed safety and tolerability, and generated effect size estimates for future trials of low-dose lithium in MCI.
Gildengers AG et al. · JAMA neurology (2026)
In plain English: Future adequately powered RCTs with cognition as a primary endpoint, functional measures, and biomarker outcomes are warranted to clarify lithium's role as a maintenance treatment in psychiatric disorders and its potential neuroprotective effects in neurodegenerative diseases.
Deng R, Shargorodsky A, Teopiz K, Dri CE, Wong S, Le GH, Zheng YJ, McIntyre RS. · CNS spectrums (2026)
In plain English: A definitive larger trial is needed to determine the efficacy of lithium in this cohort.
Rice SM, Nelson B, Amminger GP, Francey SM, Phillips LJ, Simmons MB, Ross M, Yuen HP, Yung AR, O'Gorman K, McGorry PD, Wood SJ, Berger GE. · Early intervention in psychiatry (2024)